Crossmark

Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985–2016

Crossref DOI link: https://doi.org/10.1007/s10875-021-01199-w

Published Online: 2022-01-04

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miyamoto, Satoshi

Umeda, Katsutsugu

Kurata, Mio

Yanagimachi, Masakatsu

Iguchi, Akihiro

Sasahara, Yoji

Okada, Keiko

Koike, Takashi

Tanoshima, Reo

Ishimura, Masataka

Yamada, Masafumi

Sato, Maho

Takahashi, Yoshiyuki

Kajiwara, Michiko

Kawaguchi, Hiroshi

Inoue, Masami

Hashii, Yoshiko

Yabe, Hiromasa

Kato, Koji

Atsuta, Yoshiko

Imai, Kohsuke https://orcid.org/0000-0003-2132-8403
Morio, Tomohiro
Funding

Funding for this research was provided by:

Ministry of Health, Labour and Welfare (20FC1053)

Japan Agency for Medical Research and Development (JP19lk0201100, JP19gk0110041)
License Information

Text and Data Mining valid from 2022-01-04

Version of Record valid from 2022-01-04
More Information

Article History

Received: 11 May 2021

Accepted: 12 December 2021

First Online: 4 January 2022

Declarations

:

: The studies involving human participants were reviewed and approved by the Institutional Review Boards at the Japanese Society for Transplantation and Cellular Therapy (JSTCT) and Tokyo Medical and Dental University.

: All participants (and/or their guardians) provided written informed consent for research use of their data and publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below